Citadel Advisors LLC bought a new position in Conifer Holdings, Inc. (NASDAQ:CNFR – Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The fund bought 22,412 shares of the insurance provider’s stock, valued at approximately $26,000. Citadel Advisors LLC owned 0.18% of Conifer as of its most recent filing with the SEC.
Separately, Nemes Rush Group LLC purchased a new position in shares of Conifer in the 4th quarter worth approximately $48,000. 34.88% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity at Conifer
In other Conifer news, Director Joseph D. Sarafa acquired 100,000 shares of the company’s stock in a transaction that occurred on Monday, April 7th. The stock was bought at an average price of $0.53 per share, for a total transaction of $53,000.00. Following the acquisition, the director now directly owns 350,000 shares in the company, valued at $185,500. The trade was a 40.00% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Insiders acquired a total of 138,000 shares of company stock worth $75,320 in the last quarter. 50.90% of the stock is owned by company insiders.
Conifer Price Performance
Conifer (NASDAQ:CNFR – Get Free Report) last posted its quarterly earnings data on Wednesday, May 14th. The insurance provider reported ($0.30) earnings per share (EPS) for the quarter. Conifer had a net margin of 34.76% and a negative return on equity of 335.82%.
Conifer Company Profile
Conifer Holdings, Inc, an insurance holding company, engages in the sale of property and casualty insurance products. The company offers insurance coverage in specialty commercial and personal product lines. It also underwrites various specialty insurance products, including property, general liability, liquor liability, automobile, and homeowners and dwelling policies.
Recommended Stories
- Five stocks we like better than Conifer
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Ignore the Noise—Samsara Stock Is Still a Strong Buy
- How to Invest in Biotech Stocks
- 3 Stocks Set to Double—And There’s Still Time to Buy
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- Analysts Can’t Get Enough of These Little-Known Biopharma Stocks
Receive News & Ratings for Conifer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Conifer and related companies with MarketBeat.com's FREE daily email newsletter.